Contineum Therapeutics Inc (CTNM)

Jun 16, 2026

Number of shareholders of Contineum Therapeutics, Inc. – NASDAQ:CTNM - TradingView

Jun 16, 2026

Jun 14, 2026

CTNM Q1 2026 Earnings: Narrower-than-Expected Loss Surprises MarketsProfit Announcement - newsline.com

Jun 14, 2026

Jun 09, 2026

CTNM: PIPE-791 advances in IPF with strong differentiation, robust pipeline, and solid financial runway - TradingView

Jun 09, 2026

Jun 09, 2026

CTNM: PIPE-791 advances in IPF with best-in-class potential, strong safety, and robust clinical momentum - TradingView

Jun 09, 2026

Jun 02, 2026

Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance

Jun 02, 2026

Jun 01, 2026

Contineum Therapeutics CSO Daniel Lorrain sells $54,862 in stock - Investing.com

Jun 01, 2026

Jun 01, 2026

Contineum Therapeutics (CTNM) CSO sells 4,170 shares under 10b5-1 plan - Stock Titan

Jun 01, 2026

Jun 01, 2026

CTNM insider 10b5-1 sales recorded by Morgan Stanley (CTNM) - Stock Titan

Jun 01, 2026

Jun 01, 2026

Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference - Weekly Voice

Jun 01, 2026

May 29, 2026

CTNM Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesEarnings Turnaround - newsline.com

May 29, 2026

May 28, 2026

Contineum Therapeutics, Inc.Common stock (CTNM) Stock Price, News, Quote & History - FinancialContent

May 28, 2026

May 28, 2026

Contineum Therapeutics (CTNM) Retreats 1.08% – Key Support Level in FocusModified Schiff - The Legal Advocate

May 28, 2026

May 28, 2026

Contineum Therapeutics Inc. (CTNM) Q1 2026 Earnings: Narrower Loss Beats ExpectationsEarnings Beat Alert - newsline.com

May 28, 2026

May 28, 2026

Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 49.21%: Read This Before Placing a Bet - MSN

May 28, 2026

May 26, 2026

CTNM Q1 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Biotech Maintains DisciplineFinal Results - The Legal Advocate

May 26, 2026

May 25, 2026

Contineum Therapeutics (CTNM) Declines 3.55%, Testing Key Support at $13.17Swing Trade Setups - Newser

May 25, 2026

May 25, 2026

Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High? - Yahoo Finance Singapore

May 25, 2026

May 25, 2026

Contineum Therapeutics Inc. (CTNM) Q1 2026 Earnings: Clinical-Stage Biotech Reports Narrower Loss, Shares DipFinancial Data - newsline.com

May 25, 2026

May 24, 2026

CTNM Q1 2026 Earnings: Narrower-than-Expected Loss Drives Strong EPS Surprise, but Shares SlipExpert Market Insights - Newser

May 24, 2026

May 23, 2026

CTNM Q1 2026 Earnings: Narrowed Loss Exceeds Expectations as Pipeline AdvancesPre-Announcement Alert - newsline.com

May 23, 2026

May 22, 2026

CTNM Q1 2026 Earnings: Significant EPS Beat Amid Pipeline Progress, Stock Slightly DownViral Trade Signals - Newser

May 22, 2026

May 22, 2026

Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential - Yahoo Finance

May 22, 2026

May 21, 2026

CTNM Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock Rises Amid R&D ProgressTangible Book Value - The Legal Advocate

May 21, 2026

May 17, 2026

Contineum Therapeutics Stock Edges Higher As PIPE-791 Pain Data Clears Safety Bar - MSN

May 17, 2026

May 15, 2026

RA Capital affiliates report 1.296M shares of Contineum (CTNM) - Stock Titan

May 15, 2026

May 15, 2026

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 15, 2026

May 15, 2026

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance

May 15, 2026

May 15, 2026

Balyasny Group (CTNM) reports 2.42M shares via ADMF, ~7.40% stake - Stock Titan

May 15, 2026

May 14, 2026

Morgan Stanley Raises Price Target on Contineum Therapeutics to $16 From $14, Keeps Equalweight Rating - Moomoo

May 14, 2026

May 14, 2026

Contineum Therapeutics, Inc. Stock 12‑Month Price Target Raised to $22.33, Implies 58% Upside - TradingView

May 14, 2026

May 13, 2026

Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference - BioSpace

May 13, 2026

May 12, 2026

Stream Contineum’s 2026 RBC Global Healthcare Conference talk live - Stock Titan

May 12, 2026

May 12, 2026

Ring Energy Announces Proposed Public Offering of Common Stock - Weekly Voice

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference - BioSpace

May 12, 2026

May 11, 2026

Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail

May 11, 2026

May 11, 2026

RBC Capital Maintains Contineum Therapeutics (CTNM) Outperform Recommendation - MSN

May 11, 2026

May 11, 2026

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

May 11, 2026

May 09, 2026

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Entrada Therapeutics Inc (TRDA) and Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail

May 09, 2026

May 08, 2026

CTNM SEC FilingsContineum Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

May 08, 2026